BioSpace News Archive

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the H.C. Wainwright 21st Annual Healthcare Conference on September 9, 2019 in New York, NY.

National medical device provider opening new locations for fastest response to meet hospitals’ equipment, service needs

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three and nine months ended June 30, 2019.

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced that members of its senior management team are scheduled to participate in two upcoming investor conferences.

The ranks of Medicare Advantage (MA) Plans are growing not only in number, but also in sophistication, observes Patrick Phillips, CEO of Cavulus, a leading technology firm that serves the MA industry

Pallium Canada welcomes the release of Health Canada’s Action Plan on Palliative Care: Building on the Framework on Palliative Care in Canada.

Recently Established Council Will Guide National Strategy to Support Family Caregivers

Scientists at the University of Birmingham have created an antimicrobial coating for steel surfaces which has proven to rapidly kill bacteria that cause some of the most common hospital-acquired infections.

Cedar Falls office added in response to community requests for services

Amgen (NASDAQ: AMGN) today announced the presentation of 14 cardiovascular scientific research abstracts, including studies evaluating the safety and efficacy of Repatha® (evolocumab) by race and ethnicity and further examining its clinical benefit in patients with familial hypercholesterolemia (FH)